Vaccine. 2007 Oct 16;25(42):7372-8. Epub 2007 Aug 28.

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.

Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, O'Shea AF, Gruber WC, Murphy BR.

Source

Vanderbilt University, Nashville, TN, USA. peter.wright@vanderbilt.edu

Abstract

Early in the development of respiratory syncytial virus (RSV) vaccines severe disease occurred in children after receipt of formalin-inactivated RSV vaccine. Continuing efforts to develop an appropriately attenuated and immunogenic live RSV vaccine have given opportunities to assure that live vaccines are safe through surveillance of children after vaccination. In the present study, the rate of RSV-associated upper respiratory tract illness in 388 children was lower in RSV vaccinated children than in controls (14% versus 20% in a 6-24 month old group and 16% versus 25% in infants). Additionally, there was no evidence that vaccination predisposed to more severe lower respiratory tract illness. Thus infection with a series of live attenuated RSV vaccines did not result in enhanced disease upon infection with wild type RSV. The impact of RSV during this surveillance will inform the design of future efficacy studies with RSV vaccines.

PMID:: 17868959; [PubMed - indexed for MEDLINE]
PMCID:: PMC2760483

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Respiratory Syncytial Virus Infections - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. [J Infect Dis. 2005]
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, Polack FP, Randolph VB, Deatly A, Hackell J, et al. J Infect Dis. 2005 Apr 1; 191(7):1093-104. Epub 2005 Mar 1.
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone. [J Virol. 2002]
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
Schmidt AC, Wenzke DR, McAuliffe JM, St Claire M, Elkins WR, Murphy BR, Collins PL. J Virol. 2002 Feb; 76(3):1089-99.
Review Clinical experience with respiratory syncytial virus vaccines. [Pediatr Infect Dis J. 2003]
Review Clinical experience with respiratory syncytial virus vaccines.
Piedra PA. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S94-9.
The future of respiratory syncytial virus vaccine development. [Pediatr Infect Dis J. 2004]
The future of respiratory syncytial virus vaccine development.
Polack FP, Karron RA. Pediatr Infect Dis J. 2004 Jan; 23(1 Suppl):S65-73.
Review Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development. [Vaccine. 2001]
Review Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development.
Brandenburg AH, Neijens HJ, Osterhaus AD. Vaccine. 2001 Apr 6; 19(20-22):2769-82.

See reviews... See all...

Cited by 10 PubMed Central articles

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine. [Virol J. 2011]
Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine.
Krause A, Xu Y, Ross S, Wu W, Joh J, Worgall S. Virol J. 2011 Jul 29; 8:375. Epub 2011 Jul 29.
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. [Proc Natl Acad Sci U S A. 2011]
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.
Swanson KA, Settembre EC, Shaw CA, Dey AK, Rappuoli R, Mandl CW, Dormitzer PR, Carfi A. Proc Natl Acad Sci U S A. 2011 Jun 7; 108(23):9619-24. Epub 2011 May 17.
A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats. [Virol J. 2010]
A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats.
Widjojoatmodjo MN, Boes J, van Bers M, van Remmerden Y, Roholl PJ, Luytjes W. Virol J. 2010 Jun 2; 7:114. Epub 2010 Jun 2.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The absence of enhanced disease with wild type respiratory syncytial virus infec...
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.
Vaccine. 2007 Oct 16 ;25(42):7372-8. Epub 2007 Aug 28 .

PubMed
HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding...
HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
J Virol Methods. 2007 Dec ;146(1-2):266-73. Epub 2007 Sep 14 .

PubMed
Endothelial cell loss after descemet stripping with endothelial keratoplasty inf...
Endothelial cell loss after descemet stripping with endothelial keratoplasty influencing factors and 2-year trend.
Ophthalmology. 2008 May ;115(5):857-65. Epub 2007 Sep 14 .

PubMed
Arthroscopically assisted ankle fusion in patients with end-stage tuberculosis.
Arthroscopically assisted ankle fusion in patients with end-stage tuberculosis.
Arthroscopy. 2007 Sep ;23(9):919-22.

PubMed
Renal sodium handling and nighttime blood pressure.
Renal sodium handling and nighttime blood pressure.
Semin Nephrol. 2007 Sep ;27(5):565-71.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 10 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information